Trends in antibiotic prescribing in general internal medicine wards: Antibiotic use and indication for prescription

Clinical Microbiology and Infection

Volumn 6, Issue 1, 2000, Pages 41-44

  Maraha, B ^a   Bonten, M ^b   Fiolet, H ^c   Stobberingh, E ^c  

^a Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DILOXANIDE; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; MACROLIDE; METRONIDAZOLE; NORFLOXACIN; OFLOXACIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIMENTIN; TINIDAZOLE;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG INDICATION; DRUG USE; FEMALE; GRAM STAINING; HOSPITAL INFECTION; HUMAN; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; SIDE EFFECT; SKIN INFECTION; SOFT TISSUE INFECTION; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS);

EID: 0033993408     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2000.00015-1.x     Document Type: Article

References (14)

1. Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance. Report of the national nosocomial resistance surveillance group. Diag Microbiol Infect Dis 1992; 15 (Suppl.): S37-42.
2. Levy SB. Antibiotic availability and use: consequences to man and his environment. J Clin Epidemiol 1991; 44 (Suppl. II): S83-7.
3. Bates DW, Spell N, Cullen DJ et al. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277: 307-11.
4. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. JAMA 1997; 277: 301-6.
5. Levy SB. Starting life resistance-free. N Eng J Med 1997; 323: 335-7.
6. Stobberingh E, Janknegt R, Wijnands G. Antibiotic guidelines and antibiotic utilization in Dutch hospitals. J Antimicrob Chemother 1993; 32: 153-61.
7. Gould IM, Hampson J, Tylor EW, Wood MJ. Working Party Report, Hospital antibiotic control measures in the UK. J Antimicrob Chemother 1994; 34: 21-42.
8. Gyssens IC. Optimizing antimicrobial drug utilization. Studies and interventions in a University hospital. PhD Thesis, The Netherlands: Catholic University of Nijmegen, 1996: 127-165.
9. Moss F, McNicol MW, McSwiggan DA, Miller DL. Survey of antibiotic prescribing in a district general hospital. I Pattern of use. Lancet 1981; ii: 349-52.
10. Bothe R, van Fourth R, van den Broek PJ. Aetiology of community-acquired pneumonia; a prospective study among adults requiring admission to hospital. Thorax 1995; 50: 543-7.
11. Ramirez JA, Srinath L, Akkee S, Huang A, Raff MJ. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch Intern Med 1995; 155: 1273-6.
12. Gentry LO, Rodriguez-Gomez G, Kohler RB, Khan FA, Rytel MW. Parenteral followed by oral ofloxacin for nosocomial pneumonia and community-acquired pneumonia requiring hospitalization. Am Rev Respir Dis 1992; 145: 31-5.
13. Yoshikawa TT. Antimicrobial therapy for the elderly patient. J Am Geriatr Soc 1990; 38: 1353-72.
14. Goldman DA, Weinstein RA, Wenzel RP et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996; 275: 234-40.